Name a common PCR inhibitor and a general mitigation strategy.

Name a common PCR inhibitor and a general mitigation strategy.

• A. EDTA, heparin, humic substances; mitigate by purification or using inhibitor-tolerant polymerases.
• B. Oxygen; mitigate by reducing temperature.
• C. Nitrogen; mitigate by increasing substrate.
• D. Argon; mitigate by removing inert gas.

Answer: (A)

PCR inhibitors are substances that interfere with the DNA polymerase during amplification, reducing or preventing the reaction from working. A common set of inhibitors includes EDTA, heparin, and humic substances. EDTA chelates magnesium ions, which are essential cofactors for the polymerase, directly hindering DNA synthesis. Heparin can interfere with the enzyme’s activity or binding to DNA, while humic substances from environmental samples can bind DNA or the polymerase, stalling amplification. A practical way to deal with these inhibitors is to purify the DNA to remove them before the PCR, restoring the necessary conditions for efficient amplification. When purification isn’t feasible or additional robustness is needed, using polymerases designed to tolerate inhibitors or adding supportive reagents can help. These strategies aim to restore enzyme activity and allow accurate amplification even in the presence of inhibitory substances. The other options don’t reflect real PCR inhibitor scenarios or effective mitigation. Oxygen isn’t typically treated by simply lowering temperature in PCR context, and nitrogen or argon gases don’t influence the reaction.

PCR inhibitors are substances that interfere with the DNA polymerase during amplification, reducing or preventing the reaction from working. A common set of inhibitors includes EDTA, heparin, and humic substances. EDTA chelates magnesium ions, which are essential cofactors for the polymerase, directly hindering DNA synthesis. Heparin can interfere with the enzyme’s activity or binding to DNA, while humic substances from environmental samples can bind DNA or the polymerase, stalling amplification.

A practical way to deal with these inhibitors is to purify the DNA to remove them before the PCR, restoring the necessary conditions for efficient amplification. When purification isn’t feasible or additional robustness is needed, using polymerases designed to tolerate inhibitors or adding supportive reagents can help. These strategies aim to restore enzyme activity and allow accurate amplification even in the presence of inhibitory substances.

The other options don’t reflect real PCR inhibitor scenarios or effective mitigation. Oxygen isn’t typically treated by simply lowering temperature in PCR context, and nitrogen or argon gases don’t influence the reaction.